在系统性缺氧下和生活在高海拔地区的人群中发展的人类瘤中的融合基因适应
Carlota Arenillas1,2,3, Lucía Celada4,5, José Ruiz-Cantador6
1Biomarkers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Cancer discovery
|April 8, 2025
概括
在自然人群和瘤中对低氧条件 (低氧) 的遗传适应显示出了显著的相似性. 这种融合为了解癌症和开发创新的癌症疗法提供了新的途径.
科学领域:
- 进化生物学是进化的生物学.
- 癌症研究 癌症研究
- 遗传学 是一个遗传学.
背景情况:
- 瘤通常会出现低氧条件 (低氧).
- 自然种群在进化过程中适应了低氧环境.
研究的目的:
- 在自然人群和瘤中研究适应低氧的遗传基础.
- 探索这两个不同的生物背景之间的潜在并行.
主要方法:
- 来自低氧环境的生物和瘤的比较基因组分析.
- 识别保存的遗传通路和分子机制.
主要成果:
- 在自然种群和瘤之间观察到遗传适应缺氧的显著重叠.
- 参与低氧适应的关键基因和调节网络在各种生物系统中共享.
结论:
- 对缺氧的遗传适应是一种融合过程,可以在进化和病理上下文中观察到.
- 了解自然缺氧适应可以为瘤生物学提供新的见解.
- 这种趋同凸显了癌症治疗的潜在新疗法目标.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Hypoxia
848
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
848
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


